A small five percent charge will be directly reinvested into research for next-generation malaria vaccines or vaccines for other neglected diseases.
Ebitundu bitaano ku buli kikumi eza ssente zijja kussibwa mu kunoonyereza ku ddagala ly'omusujja ery'omulembe oguddako ne mu malagala g'endwadde endala ezibuusiddwa amaaso.